International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2021 - Volume 25, Number 5
View All Articles in Issue

Page(s): 421

Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 . Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, spironolactone, formulation, oral suspension, potassium-sparing diuretic, high blood pressure, hypertension, edema, acne, antihypertensive agent

Related Categories: DERMATOLOGY, FORMULATIONS, CARDIOLOGY, UROLOGY/URINARY TRACT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Spironolactone 5 mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 496
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V	Jul/Aug 2017 Pg. 334-338
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 147
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Valsartan 4-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2021 Pg. 329
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526